Cargando…
Emerging options in growth hormone therapy: an update
Growth hormone (GH) was first used to treat a patient in 1958. For the next 25 years it was available only from cadaver sources, which was of concern because of safety considerations and short supply. In 1985, GH produced by recombinant DNA techniques became available, expanding its possible uses. S...
Autores principales: | Kemp, Stephen F, Frindik, J Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180516/ https://www.ncbi.nlm.nih.gov/pubmed/21966214 http://dx.doi.org/10.2147/DDDT.S23140 |
Ejemplares similares
-
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
por: Frindik, J Paul, et al.
Publicado: (2010) -
Update on Emerging Treatment Options for Primary Biliary Cholangitis
por: Aguilar, Maria T, et al.
Publicado: (2020) -
Polycythemia Vera (PV): Update on Emerging Treatment Options
por: Benevolo, Giulia, et al.
Publicado: (2021) -
An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022) -
Do Not Forget about Hormonal Therapy for Recurrent Endometrial Cancer: A Review of Options, Updates, and New Combinations
por: Wagner, Vincent M., et al.
Publicado: (2023)